Evidence map›Paper›PMID 38953039›Full record

ArticleTransplantation direct2024

Baseline Lung Allograft Dysfunction After Bilateral Lung Transplantation Is Associated With an Increased Risk of Death: Results From a Multicenter Cohort Study.

Michael B Keller, Junfeng Sun, Muhtadi Alnababteh, Lucia Ponor, Pali D Shah, Joby Mathew, Hyesik Kong, Ananth Charya, Helen Luikart, Shambhu Aryal and 5 more

Abstract read
In one paragraph

Article in Transplantation direct, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Utility of donor-derived cell-free DNA testing after lung transplantation in the precision medicine era.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Post-lung transplant surveillance in 2026: current practice, variability, and the need for standardization.Transplant international : official journal of the European Society for Organ Transplantation · 2026
    Review
  11. Impact of donor specific antibodies on longitudinal lung function and baseline lung allograft dysfunction.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. %dd-cfDNA: The New Frontier for Heart/Lung Transplant Surveillance?Transplant international : official journal of the European Society for Organ Transplantation · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Michael B KellerLaborarory of Applied Precision Omics (APO), National Institutes of Health, Bethesda, MD.
Junfeng SunAdvanced Lung Disease Program and Lung Transplant Program, Inova Fairfax Hospital, Falls Church, VA.
Muhtadi AlnababtehLaborarory of Applied Precision Omics (APO), National Institutes of Health, Bethesda, MD.
Lucia PonorGenomic Research Alliance for Transplantation (GRAfT), Bethesda, MD.
Pali D ShahGenomic Research Alliance for Transplantation (GRAfT), Bethesda, MD.
Joby MathewGenomic Research Alliance for Transplantation (GRAfT), Bethesda, MD.
Hyesik KongLaborarory of Applied Precision Omics (APO), National Institutes of Health, Bethesda, MD.
Ananth CharyaDivision of Pulmonary and Critical Care Medicine, University of Maryland Medical Center, Baltimore, MD.
Helen LuikartGenome Transplant Genomics (GTD), Stanford University School of Medicine, Palo Alto, CA.
Shambhu AryalGenomic Research Alliance for Transplantation (GRAfT), Bethesda, MD.
Steven D NathanGenomic Research Alliance for Transplantation (GRAfT), Bethesda, MD.
Jonathan B OrensGenomic Research Alliance for Transplantation (GRAfT), Bethesda, MD.
Kiran K KhushGenome Transplant Genomics (GTD), Stanford University School of Medicine, Palo Alto, CA.
Moon Kyoo JangLaborarory of Applied Precision Omics (APO), National Institutes of Health, Bethesda, MD.
Sean Agbor-EnohLaborarory of Applied Precision Omics (APO), National Institutes of Health, Bethesda, MD.ORCID https://orcid.org/0000-0002-9380-9161

Funding

Use of donor-derived cell-free DNA for risk stratification and post-treatment monitoring of lung transplant patients at risk for chronic lung allograft dysfunctionK22HL166368 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI Michael Keller · 2025 to 2026
$498k
NHLBI NIH HHS K22 HL166368
6 · The paper itself

Abstract

Background: A prior single-center, retrospective cohort study identified baseline lung allograft dysfunction (BLAD) as a risk factor for death in bilateral lung transplant recipients. In this multicenter prospective cohort study, we test the association of BLAD with death in bilateral lung transplant recipients, identify clinical risk factors for BLAD, and assess its association with allograft injury on the molecular level. Methods: This multicenter, prospective cohort study included 173 bilateral lung transplant recipients that underwent serial pulmonary function testing and plasma collection for donor-derived cell-free DNA at prespecified time points. BLAD was defined as failure to achieve ≥80% predicted for both forced expiratory volume in 1 s and forced vital capacity after lung transplant, on 2 consecutive measurements at least 3 mo apart. Results: BLAD was associated with increased risk of death (hazard ratio, 1.97; 95% confidence interval [CI], 1.05-3.69; Conclusions: BLAD is associated with an increased risk of death following lung transplantation, representing an important posttransplant outcome with valuable prognostic significance; however, early allograft specific injury on the molecular level does not increase the risk of BLAD, supporting further mechanistic insight into disease pathophysiology.

Identifiers

PMID38953039
PMCPMC11216668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.